116 related articles for article (PubMed ID: 18005334)
1. Comparative molecular field analysis of quinoline derivatives as selective and noncompetitive mGluR1 antagonists.
Sekhar YN; Nayana MR; Ravikumar M; Mahmood SK
Chem Biol Drug Des; 2007 Dec; 70(6):511-9. PubMed ID: 18005334
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach.
Puntambekar D; Giridhar R; Yadav MR
Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255
[TBL] [Abstract][Full Text] [Related]
4. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1.
Nataraja Sekhar Y; Ravikumar M; Ravi Shashi Nayana M; Mallena SC; Kishore Kumar M
Eur J Med Chem; 2008 May; 43(5):1025-34. PubMed ID: 17822809
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method.
Temiz-Arpaci O; Tekiner-Gulbas B; Yildiz I; Aki-Sener E; Yalcin I
Bioorg Med Chem; 2005 Dec; 13(23):6354-9. PubMed ID: 15993083
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR and docking studies of aldehyde inhibitors of human cathepsin K.
Pan X; Tan N; Zeng G; Han H; Huang H
Bioorg Med Chem; 2006 Apr; 14(8):2771-8. PubMed ID: 16377193
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR design of novel antiepileptic sulfamides.
Gavernet L; Dominguez Cabrera MJ; Bruno-Blanch LE; Estiú GL
Bioorg Med Chem; 2007 Feb; 15(3):1556-67. PubMed ID: 17158052
[TBL] [Abstract][Full Text] [Related]
9. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors.
Teixeira C; Barbault F; Rebehmed J; Liu K; Xie L; Lu H; Jiang S; Fan B; Maurel F
Bioorg Med Chem; 2008 Mar; 16(6):3039-48. PubMed ID: 18226912
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR and molecular docking studies of selective agonists for the thyroid hormone receptor beta.
Du J; Qin J; Liu H; Yao X
J Mol Graph Model; 2008 Sep; 27(2):95-104. PubMed ID: 18436460
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR studies on the inhibitors of AP-1 and NF-kappaB mediated transcriptional activation.
Qin J; Liu H; Li J; Ren Y; Yao X; Liu M
Eur J Med Chem; 2009 Jul; 44(7):2888-95. PubMed ID: 19128859
[TBL] [Abstract][Full Text] [Related]
13. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
Holder S; Lilly M; Brown ML
Bioorg Med Chem; 2007 Oct; 15(19):6463-73. PubMed ID: 17637507
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA.
Gueto C; Ruiz JL; Torres JE; Méndez J; Vivas-Reyes R
Bioorg Med Chem; 2008 Mar; 16(5):2439-47. PubMed ID: 18065233
[TBL] [Abstract][Full Text] [Related]
15. CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors.
Kulkarni SS; Patel MR; Talele TT
Bioorg Med Chem; 2008 Apr; 16(7):3675-86. PubMed ID: 18299198
[TBL] [Abstract][Full Text] [Related]
16. CoMFA and docking studies of 2-phenylindole derivatives with anticancer activity.
Liao SY; Qian L; Miao TF; Lu HL; Zheng KC
Eur J Med Chem; 2009 Jul; 44(7):2822-7. PubMed ID: 19167135
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
18. CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors.
Shashi Nayana MR; Sekhar YN; Siva Kumari N; Mahmood SK; Ravikumar M
Eur J Med Chem; 2008 Jun; 43(6):1261-9. PubMed ID: 17825954
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR CoMFA studies on bis-coumarine analogues as urease inhibitors: a strategic design in anti-urease agents.
Zaheer-ul-Haq ; Lodhi MA; Ahmad Nawaz S; Iqbal S; Mohammed Khan K; Rode BM; Atta-ur-Rahman ; Choudhary MI
Bioorg Med Chem; 2008 Mar; 16(6):3456-61. PubMed ID: 18280742
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists.
Barreca ML; Gitto R; Quartarone S; De Luca L; De Sarro G; Chimirri A
J Chem Inf Comput Sci; 2003; 43(2):651-5. PubMed ID: 12653534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]